Safety Study in Outpatient Japanese Children With ADHD

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

October 31, 2003

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Atomoxetine Hydrochloride

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tokyo

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00485628 - Safety Study in Outpatient Japanese Children With ADHD | Biotech Hunter | Biotech Hunter